ADRB1 and breast carcinoma: Based on the limited information available on the role of βAR in breast cancer, particularly β1AR, it is premature to draw any conclusions of the pathophysiological significance GPR30-promoted inhibition of β1AR-stimulated cAMP production in this disorder.